BALCX | JABAX | BALCX / JABAX | |
Total Expense Ratio | 1.31 | 0.82 | 160% |
Annual Report Gross Expense Ratio | 1.31 | 0.82 | 160% |
Fund Existence | 24 years | 33 years | - |
Gain YTD | 6.359 | 6.670 | 95% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 2500 | 10% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 248B | 26.1B | 950% |
Annual Yield % from dividends | 1.24 | 1.80 | 69% |
Returns for 1 year | 6.55 | 5.82 | 112% |
Returns for 3 years | 30.15 | 33.35 | 90% |
Returns for 5 years | 38.33 | 45.15 | 85% |
Returns for 10 years | 56.79 | 85.65 | 66% |
1 Day | |||
---|---|---|---|
STOCK / NAME | Price $ | Chg $ | Chg % |
MREO | 2.80 | 0.08 | +2.94% |
Mereo BioPharma Group plc | |||
BTSG | 23.08 | 0.47 | +2.08% |
BrightSpring Health Services | |||
PAC | 224.82 | 1.25 | +0.56% |
Grupo Aeroportuario del Pacifico SAB de CV Amer Dep Shares (each rep 10 Ser B shares) | |||
CHSCM | 24.04 | -0.08 | -0.33% |
CHS | |||
NINE | 0.76 | -0.06 | -6.84% |
Nine Energy Service |